Germany Alopecia (Hair Loss) Therapeutics Market Analysis

Germany Alopecia (Hair Loss) Therapeutics Market Analysis


$ 3999

The Germany Alopecia (Hair Loss) Therapeutics Market was valued at US $300 Mn in 2022, and is predicted to grow at (CAGR) of 5.7% from 2023 to 2030, to US $468 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of alopecia (hair loss), supportive government initiatives, technological advancements, and others. The industry is primarily dominated by players such as, Eli Lilly, Merck, Pfizer, Bayer, Valeant Pharmaceuticals, and iRestore, among others.

ID: IN10DEPH430 CATEGORY: Pharmaceuticals GEOGRAPHY: Germany AUTHOR: Riddhi Solanki

Buy Now

Germany Alopecia Therapeutics Market Analysis: Executive Summary

The Germany Alopecia (Hair Loss) Therapeutics Market is at around US $300 Mn in 2022 and is projected to reach US $468 Mn in 2030, exhibiting a CAGR of 5.7% during the forecast period.

Alopecia, characterized by atypical hair loss, is an autoimmune hereditary disorder that affects a significant number of individuals. It presents in various forms, including localized or diffuse, temporary or permanent, and can impact individuals of all ages and genders. The condition is linked to multiple risk factors such as heightened stress levels, diabetes, inadequate nutrition, and environmental influences, resulting in notable distress among patients and influencing their overall quality of life. Common symptoms include hair loss, thinning hair, and bald patches on the scalp. Treatment options encompass applying topical medications like Minoxidil or corticosteroids directly to the scalp, as well as using injections and oral medications with more potent immunosuppressive effects. Light therapy and hair transplantation are also feasible alternatives. Companies such as Eli Lilly, with their JAK inhibitor Baricitinib, and Bayer, with Rogaine (minoxidil), are actively leading advancements in treatments for this condition.

The overall prevalence of alopecia is around 210/1,00,000 individuals in Germany. The increased prevalence of alopecia in Germany is caused by risk factors like chronic conditions like diabetes, environmental changes, and poor nutrition. The market is being fuelled by crucial factors such as the growing aging population and the increasing prevalence of alopecia, supportive government policies, and technological advancements in the therapeutics industry. However, challenges such as high costs of treatments like gene therapy, limited coverage, and limited market accessibility are a few factors that limit the market's potential.

Germany Alopecia Therapeutics (Hair Loss) Market Analysis 2022 to 2030

Market Dynamics

Market Growth Drivers

Surge in prevalence of Alopecia: The overall prevalence of alopecia is estimated at 210/1,00,000 individuals, and the incidence is around 72/1,00,000 individuals in Germany. Around 41.2% of men in Germany undergo hair loss by the age of about 43 years, indicating the substantial demand for treatments that are effective. These estimates create a considerable pool of patients requiring advanced treatments, driving the market.

Government initiatives: Germany's robust healthcare system, coupled with extensive insurance coverage (social health insurance), creates a conducive environment for market expansion. Although certain treatments, such as JAK inhibitors, face challenges, government initiatives are advocating for enhanced reimbursement options, thereby expanding potential patient access.

Technological advancements: Advancements in hair analysis technology and diagnostic tools contribute to an improved understanding of alopecia subtypes and personalized treatment strategies, resulting in more effective care. The expansion of telemedicine and online consultations enhances access to specialists and treatment guidance, particularly in rural areas of Germany.

Advanced treatment options: The approval of Baricitinib (Olumiant) and the expected authorization of Rinvoq introduce novel oral medication alternatives that have the potential for enhanced efficacy and improved convenience compared to older treatments. Ongoing research in the evolving pipeline is dedicated to innovative therapies targeting different pathways related to alopecia, offering prospects for even more effective and personalized treatment options in the future.

Market Restraints

High costs of medications: JAK inhibitors such as Xeljanz and Baricitinib frequently exceed the standard limits of insurance coverage, resulting in substantial expenses for many patients. The financial strain is exacerbated by the costs of topical treatments and surgical procedures, creating difficulties for individuals with limited incomes to afford these therapies.

Limited coverage: While insurance plans might encompass certain alopecia treatments, particular medications or procedures like hair transplantation may be excluded or entail significant co-payments. This affects affordability and can shape decisions regarding care. Consequently, patients may bear the burden of co-payments, resulting in non-compliance with treatment and constraining market growth.

Limited accessibility: Limited access to specialists and specialized medications in rural areas results in geographic disparities in healthcare delivery in Germany. Despite having insurance coverage, some patients may still face restrictions on the number of treatment sessions or specific procedures, limiting their access to care.

Notable Updates

July 2023, Baricitinib (Olumiant) by Eli Lilly was approved in Germany. This JAK inhibitor provides a promising oral treatment alternative for individuals with moderate-to-severe alopecia areata. This marks a noteworthy change, as JAK inhibitors were not previously accessible for treating alopecia in Germany.

Healthcare Policies and Regulatory Landscape

Germany's healthcare policy and regulatory landscape are overseen by several pivotal authorities and agencies. The Federal Institute for Drugs and Medical Devices (BfArM) is the primary entity tasked with healthcare regulations and licensing in Germany. BfArM handles drug approval and licensing. To secure registration and marketing authorization for pharmaceuticals and medical devices, companies must adhere to the requirements set by BfArM.

This process involves submitting technical and scientific data to validate the product's safety, quality, and effectiveness. Additionally, companies must appoint a local importer or distributor for product liability, and certain low-risk products may be exempt from the registration process. The healthcare industry in Germany provides a spectrum of opportunities for companies, encompassing both the public and private sectors. The German healthcare system is divided into three main areas: outpatient care, inpatient care (the hospital sector), and rehabilitation facilities. Managing the healthcare system involves various entities, including associations, health insurers, regulatory bodies, the Federal Ministry of Health, patient organizations, and self-help groups.

The Federal Ministry of Health plays a crucial role in policymaking and developing laws and administrative guidelines for self-governing institutions.

Competitive Landscape

Key Players

  • Eli Lilly
  • Johnson & Johnson
  • Pfizer
  • Merck & Co
  • Bayer
  • Valeant Pharmaceuticals
  • GlaxoSmithKline plc
  • Aurobindo Pharma
  • iRestore Hair Growth system
  • Theradome

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Germany Alopecia Therapeutics Market Segmentation

By Disease Type

  • Alopecia Areata
  • Cicatricial Alopecia
  • Traction Alopecia
  • Alopecia Totalis
  • Androgenetic Alopecia
  • Alopecia Universalis
  • Others

By Treatment Type

  • Pharmaceuticals
  • Devices
  • Others

By Gender

  • Male
  • Female

By Route of Administration

  • Topical
  • Injectable
  • Oral

By Age Group

  • Below 18 years
  • 18-34 years
  • 35-49 years
  • 50 years and above

By End User

  • Hospitals
  • Physician’s Office
  • Dermatology clinics
  • Others

By Sales Channel

  • Prescriptions
  • OTC

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 15 February 2024
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up